This study reports a cluster of septicaemic newborns with imipenem-resistant Escherichia coli in the blood and delineates the possible mechanisms of transmission of imipenem resistance with respect to the New Delhi metallo-b-lactamase (NDM-1) gene.
Introduction
An overwhelming proportion of neonatal deaths occur in developing countries. 1 Resource-poor settings, high population density and hygiene conditions pose a great challenge for the neonatal healthcare system. Though the development of sick newborn care units (SNCUs) at rural hospitals in India has made a difference in infant survival rates, infection control still remains a concern. 2 The options for the treatment of nosocomial infections are being severely compromised due to the increasing prevalence of carbapenem resistance in Gram-negative bacilli (GNB), limiting the choice of antibiotics to a few highly selected and costly ones. 3 Carbapenem resistance can occur due to either carbapenemase production or due to other mechanisms of resistance, such as alteration of outer membrane permeability along with extended-spectrum b-lactamase (ESBL) production or overexpression of AmpC type b-lactamases. Resistance due to carbapenemases can be because of either metallo-b-lactamases (MBLs) or non-MBLs. The production of carbapenemases is generally a more potent mechanism of carbapenem resistance compared with the other mechanisms. 3 -5 Recently, the emergence of a new MBL, designated New Delhi MBL 1 (NDM-1), has intensified the problem of drug resistance. 6 -12 Earlier studies have extensively assessed the prevalence of this gene in India. 6, 11 Most studies have reported sporadic cases of infection caused by NDM-1-producing isolates in adult patients. 7 -9,12 Moreover, NDM-1-possessing isolates have been recently reported by the current authors in two neonates from a tertiary care hospital in India. In November 2009, carbapenem-resistant GNB were isolated during a point prevalence survey carried out on a single day in the SNCU of a rural hospital in West Bengal, India. Shortly after the survey, a cluster of bloodstream infections with carbapenemresistant Escherichia coli were detected in the same unit. The present study attempts to describe the transmission of the carbapenem resistance gene in GNB isolated from the environment of the SNCU and the body sites of the neonates during the survey. Further, bacteria isolated during the survey and shortly after the survey from the blood of the septicaemic neonates were evaluated with respect to clonality, virulence factors, the bla NDM-1 gene, porins, integrons and transmissibility.
Materials and methods

Setting and description of the point prevalence survey
The point prevalence survey was carried out on a single day in a 20 bed level II SNCU in a rural hospital, West Bengal, India. The Department of Neonatology, IPGMER and SSKM Hospital, West Bengal, acts as a nodal centre for the rural SNCUs. In 2005, the nodal centre took the initiative to develop level II SNCUs in various districts. 2 In March 2009, arrangements were made for blood cultures from the Birbhum SNCU to be performed at the nodal centre. 13 In the event of a high prevalence of multidrug resistance, it was decided to conduct a point prevalence survey of the unit, its environment and the healthcare providers in November 2009. Shortly after this survey, four fresh neonates admitted to the SNCU developed septicaemia.
Collection of specimens
During the survey, four body sites of the neonates were sampled: umbilicus; groin; mouth; and rectum (henceforth referred to as body site). In addition, hand-wash specimens from doctors and nursing staff in the unit, and environmental specimens (wash basin, washing area, water dripping from air conditioner, radiant warmer, medicine tray, stethoscope and suction apparatus) were collected. Disinfectants, intravenous (iv) cannulae, syringes, unused iv fluids (10% dextrose and normal saline) and coconut oil (a source of medium-chain triglyceride for pre-term neonates) were also collected for culture. A total of 99 specimens were collected.
Neonates were suspected for sepsis on the basis of criteria set earlier by the authors.
14 For the diagnosis of sepsis, routine blood cultures were done. One millilitre of blood was drawn from the neonates suspected to have sepsis and inoculated in Peds Plus Vials (Becton Dickinson, MD, USA). Filled vials were stored at room temperature prior to transportation. At the nodal centre, delayed entry of the vials was made into the automated BACTEC 9050 system (Becton Dickinson).
Laboratory procedures
All GNB isolated from the environment of the SNCU, body sites and bloods of the neonates were identified, and antibiotic susceptibility profiles were evaluated. Detailed molecular characterization was carried out for the isolates possessing bla NDM-1 .
Identification of the strains
Survey specimens and blood cultures were plated onto MacConkey agar or 5% sheep blood agar (BD Diagnostics, Franklin Lakes, USA). Isolates were identified using ID 32 E or ID 32 GN kits (bioMérieux, Marcy l'Étoile, France).
Antimicrobial susceptibility testing and MIC
Antibiotic susceptibility testing was performed as per CLSI criteria 15 and the MIC value (mg/L) was determined using Etest (AB Biodisk, Solna, Sweden). MICs were also determined with 40 mg/L phenylalanine arginine b-naphthylamide (PAbN) (Sigma-Aldrich, St Louis, MO, USA) to investigate the possible role of efflux pumps in imipenem resistance.
PFGE, phylogenetic analysis and virulence genotyping
The clonality of all E. coli isolates was determined by PFGE following PulseNet standardized procedures (http://www.cdc.gov/pulsenet/protocols. htm) and interpreted according to the criteria of Tenover et al. 16 Further analysis of the genetic makeup of the E. coli isolates was done by evaluation of the phylogroup (A, B1, B2 and D) 17 and virulence factors (hly, papC, sfa, iroN E. coli , cnf1, iucC and ibeA).
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Detection of b-lactamase phenotypes
The production of ESBLs, carbapenemases and MBLs was evaluated using a cephalosporin/clavulanic acid combination disc test, 15 modified Hodge test and imipenem-EDTA double-disc combination test, respectively.
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AmpC b-lactamase was also investigated according to the previous study. 10 
SDS -PAGE and immunodetection of OmpA and porins
Whole-cell extracts of E. coli isolates were separated on 11% SDSpolyacrylamide gels 4 and transferred to Immobilon-P filters (Millipore) following standard procedures. Porins and outer membrane proteins were detected using polyclonal anti-OmpC/F and polyclonal anti-OmpA antibody, separately. and ampC 27 ) and also for 16S rRNA methylase-encoding genes in all E. coli isolates.
Molecular characterization of b-lactamases
12 NDM-1 was detected using primers reported previously. 10 Amplified products were further sequenced. 23, 27 The other carbapenem-resistant GNB isolated were screened for bla NDM-1 by PCR, and those found positive were then screened for other b-lactamases and 16S rRNA methylase-encoding genes.
Detection of integrons, transfer of bla NDM-1 and plasmid analysis
Plasmid analysis and detection of integrons 28 were carried out for representative isolates possessing bla NDM-1 ( Table 2 ). Conjugal transfer of bla NDM-1 to the sodium azide-resistant E. coli J53 recipient was attempted by a broth mating assay. Transconjugants were selected with 4 mg/L cefotaxime and 100 mg/L sodium azide. Plasmids of the transconjugants were analysed. 29 The presence of bla NDM-1 , bla CMY alleles and integrons in the transconjugants was confirmed by PCR. 
Ethical clearance
Results
Description of the isolates
The GNB isolated from the environmental specimens were Pseudomonas aeruginosa (two isolates), Klebsiella pneumoniae (three) and Acinetobacter junii (four). Cultures from the body sites of the neonates contained E. coli (16 isolates), Acinetobacter baumannii (7), Stenotrophomonas maltophilia (3), P. aeruginosa (2), Enterobacter cloacae (2) and K. pneumoniae (1). E. coli (n¼ 16, EC 1 -16) was the most common aerobic GNB found during the survey and was isolated from the body sites of 10 neonates (Table 1) . No E. coli were isolated from environmental specimens. None of the neonates whose body sites yielded E. coli during the point prevalence survey later developed sepsis. Shortly after the survey, four fresh neonates developed septicaemia with E. coli (EC 17 -20) . These four neonates were admitted to the SNCU after the point prevalence survey was conducted and, hence, no specimens had been collected from their body sites.
Clinical presentation of the neonates
All the four neonates with septicaemia due to imipenemresistant E. coli weighed .2000 g, all were delivered at term and the majority were extramural births (3/4). All four infected neonates had been hospitalized for ≥2 days before they developed signs of sepsis. None of these neonates was ventilated or had a central vascular catheter in place. Of the four neonates, three had perinatal risk factors (delayed cry, or foul-smelling or meconium-stained liquor) for sepsis.
Among the 10 neonates whose body sites yielded E. coli during the survey, 6 weighed ,1500 g, 2 weighed 1500 -2000 g and 2 weighed .2000 g. The majority of the neonates were pre-term and intramural births (Table 1) .
Laboratory findings
Antimicrobial susceptibility testing, MIC determination and phenotypic detection of b-lactamases All 20 E. coli isolates (16 body site and 4 blood) were found to be multidrug resistant (Table 2) . Eighteen (14 body site and 4 blood) of the 20 isolates were imipenem resistant; only 2 body site isolates of E. coli were imipenem susceptible ( Table 2 ). The MIC value of imipenem for imipenem-resistant isolates was ≥32 mg/L and PAbN had no effect on imipenem MICs.
The production of ESBL and AmpC was confirmed in all 20 E. coli isolates. Imipenem-resistant E. coli isolates (18) were found to produce MBLs.
Phylogenetic groups and virulence genes of the E. coli isolates
Assessment of the phylogroups and virulence patterns of the E. coli isolates (from body sites and blood) revealed that phylogroup A was the most frequent, accounting for 14 (imipenemresistant body site isolates) of the 20 E. coli isolates, followed by group D with 6 isolates (4 imipenem-resistant blood isolates and 2 imipenem-susceptible body site isolates) ( Table 2 ). Septicaemia was caused by E. coli of phylogroup D. Most virulence factors were not detected in the isolates, with the notable exception of papC, which was only detected in 5/20 isolates (Table 2) . papC is a P fimbriae gene conferring mannose-resistant (MR) adherence to intestinal epithelial cells. MR adhesins are wellknown virulence factors in urinary tract infection, septicaemia and meningitis. 30 Genetic diversity PFGE analysis of the E. coli isolates revealed that the isolates belonged to two different clones (X, with subtypes X1 and X2, and Y1) ( Figure 1 and Table 2 ). The patterns obtained with four blood isolates (EC 17 -20) and one of the two imipenemsusceptible isolates (EC 3) were indistinguishable (PFGE pattern X1); these five isolates possessed the same virulence factor (papC). The other imipenem-susceptible isolate, EC 2, obtained from the same patient as EC 3, showed a closely related pattern to X1, designated as X2. The 14 imipenem-resistant body site isolates were different from the bloodstream isolates and their PFGE patterns were designated as Y1. The PFGE results correlated with the PCR phylogrouping ( Table 2 ). All the E. coli body site isolates, except two (EC 2 and EC 3), were indistinguishable (pattern Y1), imipenem resistant and belonged to phylogroup A. However, all isolates that caused septicaemia had a pattern (X1) indistinguishable from that of EC 3 (X1) and closely related to EC 2 (X2), and belonged to phylogroup D.
Genetic context and DNA sequencing
Exploration for carbapenem resistance genes showed the presence of bla NDM-1 in the 18 imipenem-resistant E. coli isolates, irrespective of their clonality. The other b-lactamase genes identified were bla CTX-M group 1 , bla OXA-1 or/and bla TEM along with bla CIT genes. Sequence analysis of the isolates identified bla CTX-M-15 , bla TEM-1 , bla CMY-59 and bla CMY-42 (Table 2) . CMY-59 was identified in imipenem-resistant and imipenem-susceptible E. coli from blood and body sites, respectively. CMY-42 was identified in imipenem-resistant E. coli from body sites. The DNA sequence and deduced amino acid sequence of NDM-1 and CMY-59 from E. coli have been deposited in DDBJ/EMBL/GenBank under accession nos. AB571289 and AB587082, respectively. All NDM-1-harbouring E. coli isolates showed the presence of the rmtB gene. It was noted that the imipenem-susceptible E. coli from body sites and the imipenem-resistant E. coli from blood had identical resistance genes (Table 2) , except for rmtB and bla NDM-1 .
Western blot analysis of the outer membrane proteins
Porin (OmpC or OmpF) loss was observed in the imipenemresistant E. coli isolates (EC 1, EC 4 -16) from body sites. We believe the lost porin to be OmpF, which is generally lost or has reduced expression in most ESBL-producing E. coli; 31 OmpF also runs above OmpC in the gel system used. 32 Isolates retained normal levels of OmpA, a structural protein. All porins were detected in the imipenem-susceptible E. coli body site isolates (EC 2 and EC 3) and the imipenem-resistant E. coli blood isolates (EC 17 -20) [ Figure S1 (available as Supplementary data at JAC Online) and Table 2 ]. Hence, imipenem resistance in the blood isolates was only due to the presence of bla NDM-1 and not porin loss. ND, not determined; NA, not applicable. Antibiotics used were ampicillin, amikacin, gentamicin, ciprofloxacin, gatifloxacin, cefpodoxime, ceftriaxone, cefotaxime, ceftazidime, cefepime, imipenem, piperacillin, aztreonam, trimethoprim/sulfamethoxazole, piperacillin/tazobactam, netilmicin, ampicillin/sulbactam, minocycline, doxycycline, tigecycline, tetracycline and colistin. Type I, isolates were resistant to all antibiotics, but susceptible to minocycline, colistin, tigecycline and doxycycline; type II, isolates were resistant to all antibiotics, but susceptible to minocycline, colistin, tigecycline, doxycycline and tetracycline; type III, isolates were resistant to all antibiotics, but susceptible to minocycline, colistin and tigecycline; and type IV, isolates were resistant to all antibiotics, but susceptible to minocycline, colistin, tigecycline, doxycycline, amikacin, trimethoprim/sulfamethoxazole, netilmicin and imipenem. a '2' indicates that none of the virulence genes was present.
Transmission of bla NDM-1 in a sick newborn care unit
Detection of bla NDM-1 in imipenem-resistant GNB apart from E. coli
Imipenem-resistant GNB from the environment and body sites were screened for bla NDM-1 by PCR. Four isolates (one A. baumannii and one S. maltophilia from body sites, and two K. pneumoniae from two different wash basins) showed the presence of the bla NDM-1 gene. The DNA sequence and deduced amino acid sequence of NDM-1 from S. maltophilia have been deposited in DDBJ/EMBL/GenBank under accession no. AB614355. Other b-lactamase genes and 16S rRNA methylase genes were also present in these isolates ( Table 2) .
Detection of integrons, analysis and transfer of plasmid DNA Integron 1 was detected in all isolates that possessed bla NDM-1 .
Megaplasmids of different sizes were also isolated from the GNB harbouring the bla NDM-1 gene (Table 2) . Imipenem resistance was found to be transferable from E. coli (from body sites and blood) and S. maltophilia, but not from K. pneumoniae and A. baumannii. The bla NDM-1 and bla CMY genes, and integron 1 were detected in the transconjugants [ Figure S2 (available as Supplementary data at JAC Online) and Table 2 ].
Discussion
This study describes the sequence of events that happened in the clinical setting of an SNCU, and makes an attempt to understand the dynamics between the neonates, the environment and the GNB with respect to the bla NDM-1 gene. In addition, it elucidates the mechanism of carbapenem resistance and the presence of other b-lactamases in the context of the bla NDM-1 gene. The point prevalence survey carried out at a rural hospital led to the isolation of imipenem-resistant and imipenem-susceptible GNB from the body sites of neonates and the environment. The most prevalent imipenem-resistant organism was E. coli, which was isolated from body sites, especially in and around the anal region of the neonates. However, no E. coli were isolated from the environment.
The neonates in the SNCU during the survey were mainly stable, pre-term neonates, admitted for a substantial period (average stay of 18 days), waiting to attain the weight criteria for discharge. There was no sharing of beds or any article between the sick neonates. Shortly after the survey, imipenemresistant E. coli were isolated from the blood of four neonates who were admitted to the SNCU after the survey. Though these four neonates were admitted to the SNCU after the survey, it is evident from the dates of admission and discharge that there is an overlap in hospital stay between the neonates whose body sites yielded E. coli and those who developed septicaemia. These neonates were treated with cefotaxime and amikacin as the pre-emptive antimicrobial therapy for clinically suspected cases of septicaemia. However, this therapy could not prevent fatality in the neonates, as the E. coli isolates were later found to be imipenem resistant. After the cases of septicaemia with imipenem-resistant E. coli were detected, standard precautions were reinforced. Strict attention was paid to handwashing with liquid soap and water. In addition, hand hygiene with chlorhexidine/alcohol was introduced after this outbreak.
Detailed analysis of the E. coli isolates (from body sites and blood) with respect to their genotypes, phylogeny, resistance to carbapenem and virulence factors gave us an insight into the interplay between the isolates. Imipenem-resistant isolates that caused septicaemia were clonally and phylogenetically similar to the imipenem-susceptible E. coli isolates (from body sites), and possessed the same virulence gene papC 30 and an identical set of resistance genes, except for bla NDM-1 .
This indicated that the imipenem resistance must have been acquired by these imipenem-susceptible isolates at some point in time, probably during the period between the survey and when the neonates became infected with E. coli.
The factors responsible for carbapenem resistance were evaluated. Analysis of porins showed that the imipenem-resistant blood isolates had intact porin profiles, though b-lactamases were present. This indicated that carbapenem resistance was probably acquired. The imipenem-resistant E. coli from the body sites could be a probable source, but other imipenemresistant GNB could not be disregarded. The carbapenem resistance gene found in all the imipenem-resistant E. coli was bla NDM-1 . Since E. coli were not isolated from any environmental specimens, screening for the bla NDM-1 gene from the other imipenem-resistant GNB from the environment and body sites Roy et al.
was carried out. This search yielded two isolates of K. pneumoniae from two different wash basins, and A. baumannii and S. maltophilia from the body sites as harbouring bla NDM-1 . NDM-1-mediated resistance to carbapenems has been recently found in E. coli, K. pneumoniae, A. baumannii and S. maltophilia in many parts of India. 6, 11, 12 In accordance with previous studies, the NDM-1 producers of this study also co-produced a 16S rRNA methylase (ArmA, RmtB or RmtC). 8, 12 NDM-1-positive isolates in this study carried large plasmids ( 80 to .500 kb), corresponding to the size range reported for bla NDM-1 plasmids by other authors. 6 The possible transfer of bla NDM-1 was substantiated when integrons and the transfer of plasmids were analysed. Integron 1 was probably associated with the bla NDM-1 gene, as all imipenem-resistant GNB and their transconjugants harbouring bla NDM-1 possessed integron 1. In concordance with earlier studies, the transmissibility of a megaplasmid was confirmed in E. coli isolates and in S. maltophilia.
11 These results lead us to conclude that the promiscuous bla NDM-1 gene had disseminated in the SNCU via different GNB (E. coli, A. baumannii, S. maltophilia and/or K. pneumoniae) harbouring bla NDM-1 . Subsequently, the gene was transferred to the imipenem-susceptible E. coli body site isolates, which later caused septicaemia ( Figure S3 , available as Supplementary data at JAC Online). Hence, the imipenem-resistant E. coli that caused septicaemia were found to be clonally identical to the imipenem-susceptible E. coli from body sites.
Earlier studies showed the presence of AmpC b-lactamases along with bla NDM-1 .
6 -9 The present study reports for the first time the presence of bla CMY-59 , which is a novel AmpC b-lactamase, along with bla NDM-1 in imipenem-resistant blood isolates. The deduced amino acid sequence of CMY-59 differed from that of CMY-2 only by the substitution A231V (http:// www.lahey.org/studies/webt.htm).
This study demonstrates the transmission of bla NDM-1 in a real-life situation. It is shown that colonization does not always lead to infection, but that the transfer of resistance to certain bacterial species can cause fatal infection. E. coli are a leading cause of septicaemia in neonates, both in developing and developed countries. 33 The emergence of newer mechanisms of resistance in resource-poor facilities is worrisome. Early, costeffective and adequate detection of such new mechanisms of resistance is crucial for infection control and prevention. The experience also highlights that even in resource-poor settings, point prevalence surveys can help to understand the emergence of newer antibiotic resistance mechanisms.
